Exact Therapeutics AS (EXTX) — Net Asset Momentum
Exact Therapeutics AS (EXTX) recorded a net asset momentum of 156.2% as of December 2024, with net assets of Nkr115.55 Million NOK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Exact Therapeutics AS (EXTX) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Exact Therapeutics AS Net Asset Momentum (2017–2024)
This chart tracks Exact Therapeutics AS's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is +156.2%, with net assets of Nkr115.55 Million NOK as of December 2024. For live market cap and overall valuation, see Exact Therapeutics AS market capitalisation.
Annual Net Asset History for Exact Therapeutics AS (2017–2024)
The table below shows the complete annual net asset history for Exact Therapeutics AS from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check EXTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (NOK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Nkr115.55 Million | Nkr153.20 Million | Nkr37.65 Million | ▲ +156.2% |
| 2023 | Nkr45.10 Million | Nkr61.32 Million | Nkr16.22 Million | ▼ -30.7% |
| 2022 | Nkr65.11 Million | Nkr82.51 Million | Nkr17.40 Million | ▼ -38.4% |
| 2021 | Nkr105.74 Million | Nkr117.63 Million | Nkr11.89 Million | ▼ -33.8% |
| 2020 | Nkr159.65 Million | Nkr170.23 Million | Nkr10.58 Million | ▲ +278.0% |
| 2019 | Nkr42.24 Million | Nkr52.10 Million | Nkr9.87 Million | ▼ -26.0% |
| 2018 | Nkr57.06 Million | Nkr63.23 Million | Nkr6.17 Million | ▲ +583.7% |
| 2017 | Nkr8.35 Million | Nkr20.02 Million | Nkr11.68 Million | — |